Skip to content

Endothelial Function in Lower Extremity Bypass Grafts

Endothelial Function in Lower Extremity Bypass Grafts

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00759707
Enrollment
19
Registered
2008-09-25
Start date
2006-04-30
Completion date
2009-12-31
Last updated
2017-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease

Keywords

saphenous vein bypass grafts, flow-mediated vasodilation

Brief summary

This study will determine whether or not saphenous vein \[arterial\] bypass grafts in the leg relax in response to increases in blood flow.

Detailed description

Subjects who have undergone saphenous vein \[arterial\] bypass grafts from the femoral to above-knee popliteal artery will undergo ultrasound imaging at rest, and again after 5 minutes of blood pressure cuff occlusion of the calf. (at 1 minute and 15 minutes) Subjects will then be given sub-lingual nitroglycerin, and repeat ultrasound will be performed 3 minutes later. Following 10 minutes of rest, subjects will be given intravenous L-NMMA, a specific nitric oxide inhibitor, to help determine the responsible agent of the vein graft flow mediated dilation.

Interventions

DRUGL-N^G monomethyl arginine (L-NMMA)

L-NMMA was infused at a dose of 1 mg/kg over 10 minutes to competitively inhibit the production of nitric oxide. Ultrasound imaging of the saphenous vein \[arterial\] bypass at baseline, and following an ischemic stimulus, administration of sublingual nitroglycerin, and intravenous administration of L-NMMA.

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Masking description

Investigators who analyzed the results of vascular function testing were blinded to the participant identity.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults who have undergone femoral artery to above-knee popliteal artery saphenous vein bypass grafts

Exclusion criteria

* Amputation beyond the toes * Critical limb ischemia defined as rest pain, non-healing ulceration or gangrene * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Saphenous Vein Bypass Graft VasodilationSingle visit studyFlow-mediated, endothelium-dependent vasodilation was determined by comparing baseline vein graft diameter with vein graft diameter as measured after deflation of a 2.5-inch wide sphygmomanometric cuff that had been inflated to suprasystolic pressure for 5 minutes. The cuff was never placed directly over the graft. Vasodilation of the vein graft was determined by acquiring images at 1 minute after cuff deflation.

Countries

United States

Participant flow

Participants by arm

ArmCount
Study Population
All 19 study subjects had continuously patent femoral-to-popliteal arterial bypass with autogenous greater saphenous vein. Ultrasound imaging of saphenous vein bypass graft followed an ischemic stimulus and administration of sublingual nitroglycerin. In the last 6 consecutive subjects, L-N\^G monomethyl arginine (L-NMMA) was administered intravenously.
19
Total19

Baseline characteristics

CharacteristicStudy Population
Age, Continuous64.7 years
STANDARD_DEVIATION 9
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
White
16 Participants
Region of Enrollment
United States
19 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 19
other
Total, other adverse events
0 / 19
serious
Total, serious adverse events
0 / 19

Outcome results

Primary

Change From Baseline in Saphenous Vein Bypass Graft Vasodilation

Flow-mediated, endothelium-dependent vasodilation was determined by comparing baseline vein graft diameter with vein graft diameter as measured after deflation of a 2.5-inch wide sphygmomanometric cuff that had been inflated to suprasystolic pressure for 5 minutes. The cuff was never placed directly over the graft. Vasodilation of the vein graft was determined by acquiring images at 1 minute after cuff deflation.

Time frame: Single visit study

ArmMeasureValue (MEAN)Dispersion
Study PopulationChange From Baseline in Saphenous Vein Bypass Graft Vasodilation5.28 vein bypass graft size increase (%)Standard Error 3.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026